Showing 981 - 1,000 results of 19,611 for search '(( 50 ((we decrease) OR (mean decrease)) ) OR ( 5 ((fold decrease) OR (nn decrease)) ))', query time: 0.62s Refine Results
  1. 981
  2. 982
  3. 983
  4. 984
  5. 985

    SIVcol Nef counteracts SERINC5 by promoting its proteasomal degradation but does not efficiently enhance HIV-1 replication in human CD4+ T cells and lymphoid tissue by Dorota Kmiec (5646374)

    Published 2018
    “…<div><p>SERINC5 is a host restriction factor that impairs infectivity of HIV-1 and other primate lentiviruses and is counteracted by the viral accessory protein Nef. …”
  6. 986
  7. 987
  8. 988
  9. 989
  10. 990

    S1 Data - by Alexander Hu (14755811)

    Published 2023
    Subjects:
  11. 991
  12. 992
  13. 993
  14. 994
  15. 995
  16. 996
  17. 997

    Advancing the science of NOWS research. by Sarah E. Maylott (14560785)

    Published 2024
    “…Understanding which infants will develop NOWS soon after birth could reduce hospital stays for infants who do not develop NOWS and decrease burdens on hospitals and clinicians. We propose noninvasive clinical indicators of NOWS, including newborn neurobehavior, autonomic biomarkers, prenatal substance exposures, and socioeconomic environments. …”
  18. 998

    Protocol measures. by Sarah E. Maylott (14560785)

    Published 2024
    “…Understanding which infants will develop NOWS soon after birth could reduce hospital stays for infants who do not develop NOWS and decrease burdens on hospitals and clinicians. We propose noninvasive clinical indicators of NOWS, including newborn neurobehavior, autonomic biomarkers, prenatal substance exposures, and socioeconomic environments. …”
  19. 999

    Cry variables. by Sarah E. Maylott (14560785)

    Published 2024
    “…Understanding which infants will develop NOWS soon after birth could reduce hospital stays for infants who do not develop NOWS and decrease burdens on hospitals and clinicians. We propose noninvasive clinical indicators of NOWS, including newborn neurobehavior, autonomic biomarkers, prenatal substance exposures, and socioeconomic environments. …”
  20. 1000